The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Active Pharmaceutical ingredient Market Size, Share, and Analysis, By Type (Innovative API and Generic API), By Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), By Synthesis (Synthetic APIs and Biotech APIs), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Urology, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Active Pharmaceutical ingredient Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 239....
January 2025
646 pages
Hemoglobinopathies Market - 2024-2031
US$ 3,400.00
Hemoglobinopathies Marketis is growing with a CAGR of 10.70% during the forecast period 2026-2035. The Hemoglobinopathies Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
December 2024
44 pages
Focal Segmental Glomerulosclerosis Market - 2024-2031
US$ 3,400.00
Focal Segmental Glomerulosclerosis Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Focal Segmental Glomerulosclerosis Market emerges as a key focus in DataM Intellig...
December 2024
60 pages
Thalassemia Market - 2024-2031
US$ 3,400.00
The Thalassemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
December 2024
37 pages
Membranous Nephropathy Market - 2024-2031
US$ 3,400.00
The Membranous Nephropathy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
December 2024
48 pages
Renal Insufficiency Market - 2024-2031
US$ 3,400.00
The Renal Insufficiency Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
December 2024
45 pages
Hyperammonemia Market - 2024-2031
US$ 3,400.00
The Hyperammonemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
December 2024
40 pages
Androgenetic Alopecia Treatment Market - 2024-2031
US$ 3,400.00
Androgenetic Alopecia Treatment Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Androgenetic Alopecia Treatment Market emerges as a key focus in DataM Intelligence l...
December 2024
57 pages
Guillain-Barre Syndrome Treatment Market - 2024-2031
US$ 3,400.00
Guillain-Barre Syndrome Treatment Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Guillain-Barre Syndrome Treatment Market emerges as a key focus in DataM Intelligen...
November 2024
59 pages
Triptorelin Market - 2024-2031
US$ 3,400.00
Triptorelin Marketis is growing with a CAGR of 4.70% during the forecast period 2026-2035. The Triptorelin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...
November 2024
37 pages
Antibody-Mediated Rejection Market - 2024-2031
US$ 3,400.00
Antibody-Mediated Rejection Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The Antibody-Mediated Rejection Market emerges as a key focus in DataM Intelligence latest in...
November 2024
53 pages
Marfan Syndrome Treatment Market - 2024-2031
US$ 3,400.00
Marfan Syndrome Treatment Market reached US$ 203.5 million in 2023 and is expected to reach US$ 312.6 million by 2031, growing with a CAGR of 5.60% during the forecast period 2026-2031. The Marfan Syn...
November 2024
51 pages
Hyperphosphatemia Treatment Market - 2024-2031
US$ 3,400.00
The Hyperphosphatemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
November 2024
53 pages
Eosinophilic Disorders Market - 2024-2031
US$ 3,400.00
Eosinophilic Disorders Market reached US$ 150 million in 2023 and is expected to reach US$ 278 million by 2031, growing with a CAGR of 7.10% during the forecast period 2026-2031. The Eosinophilic Diso...
November 2024
48 pages
Tramadol Drugs Market - 2024-2031
US$ 3,400.00
The Tramadol Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
November 2024
40 pages
Diverticulitis Disease Treatment Market - 2024-2031
US$ 3,400.00
Diverticulitis Disease Treatment Marketis is growing with a CAGR of 7.70% during the forecast period 2026-2035. The Diverticulitis Disease Treatment Market emerges as a key focus in DataM Intelligence...
November 2024
58 pages
Hematuria Treatment Market - 2024-2031
US$ 3,400.00
Hematuria Treatment Marketis is growing with a CAGR of 2.80% during the forecast period 2026-2035. The Hematuria Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
November 2024
45 pages
Hemochromatosis Treatment Market - 2024-2031
US$ 3,400.00
Hemochromatosis Treatment Marketis is growing with a CAGR of 5.70% during the forecast period 2026-2035. The Hemochromatosis Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
November 2024
51 pages
Interstitial Cystitis Drugs Market - 2024-2031
US$ 3,400.00
Interstitial Cystitis Drugs Marketis is growing with a CAGR of 5.28% during the forecast period 2026-2035. The Interstitial Cystitis Drugs Market emerges as a key focus in DataM Intelligence latest in...
November 2024
53 pages
Fragile X Syndrome (Fxs) Treatment Market - 2024-2031
US$ 3,400.00
Fragile X Syndrome (Fxs) Treatment Marketis is growing with a CAGR of 6.80% during the forecast period 2026-2035. The Fragile X Syndrome (Fxs) Treatment Market emerges as a key focus in DataM Intellig...
November 2024
60 pages
Mitochondrial Myopathies Treatment Market - 2024-2031
US$ 3,400.00
The Mitochondrial Myopathies Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
November 2024
60 pages
Diabetic Gastroparesis Treatment Market - 2024-2031
US$ 3,400.00
Diabetic Gastroparesis Treatment Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Diabetic Gastroparesis Treatment Market emerges as a key focus in DataM Intelligence...
November 2024
58 pages
Ursodeoxycholic Acid Market - 2024-2031
US$ 3,400.00
Ursodeoxycholic Acid Market reached US$ 581.17 million in 2023 and is expected to reach US$ 1120.55 million by 2031, growing with a CAGR of 9.80% during the forecast period 2026-2031. The Ursodeoxycho...
November 2024
46 pages
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
Antiplatelet drugs prevent platelets from sticking together and decrease the body’s ability to form blood clots. These medications are used to treat, and may help prevent, heart attack, abnormal heart...
November 2024
146 pages
Nephrotic Syndrome Drugs Market - 2024-2031
US$ 3,400.00
Nephrotic Syndrome Drugs Market reached US$ 423.7 million in 2023 and is expected to reach US$ 645.3 million by 2031, growing with a CAGR of 5.40% during the forecast period 2026-2031. The Nephrotic S...
November 2024
50 pages
Alcoholic Hepatitis Treatment Market - 2024-2031
US$ 3,400.00
The Alcoholic Hepatitis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
November 2024
55 pages
Hyaluronidase Market - 2024-2031
US$ 3,400.00
Hyaluronidase Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Hyaluronidase Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seaso...
November 2024
39 pages
Epidermolysis Bullosa Therapeutics Market - 2024-2031
US$ 3,400.00
Epidermolysis Bullosa Therapeutics Marketis is growing with a CAGR of 7.00% during the forecast period 2026-2035. The Epidermolysis Bullosa Therapeutics Market emerges as a key focus in DataM Intellig...
November 2024
60 pages
Prescription Drugs Markets in China
US$ 4,000.00
China's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
October 2024
217 pages
Prescription Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
October 2024
93 pages
Prescription Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
October 2024
73 pages
Dyspepsia Drug Market - 2024-2031
US$ 3,400.00
The Dyspepsia Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
October 2024
40 pages
Klinefelter Syndrome Treatment Market - 2024-2031
US$ 3,400.00
The Klinefelter Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
October 2024
56 pages
Schistosomiasis Drugs Market - 2024-2031
US$ 3,400.00
Schistosomiasis Drugs Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Schistosomiasis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analy...
October 2024
47 pages
Adrenocortical Hormones API Market - 2024-2031
US$ 3,400.00
The Adrenocortical Hormones API Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
October 2024
53 pages
Lyophilized Injectable Drugs Market - 2024-2031
US$ 3,400.00
The Lyophilized Injectable Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
October 2024
54 pages
Adrenoleukodystrophy Treatment Market - 2024-2031
US$ 3,400.00
Adrenoleukodystrophy Treatment Market reached US$ 323.36 million in 2023 and is expected to reach US$ 673.03 million by 2031, growing with a CAGR of 9.60% during the forecast period 2026-2031. The Adr...
October 2024
56 pages
Juvenile Dermatomyositis Treatment Market - 2024-2031
US$ 3,400.00
Juvenile Dermatomyositis Treatment Market reached US$ 71.15 million in 2023 and is expected to reach US$ 101.93 million by 2031, growing with a CAGR of 4.60% during the forecast period 2026-2031. The...
October 2024
60 pages
Neuromyelitis Optica (Devic's Syndrome) Market - 2024-2031
US$ 3,400.00
Neuromyelitis Optica (Devic's Syndrome) Marketis is growing with a CAGR of 4.80% during the forecast period 2026-2035. The Neuromyelitis Optica (Devic's Syndrome) Market emerges as a key focus in Data...
October 2024
65 pages
Global Heart Failure Therapeutics Market Size Study, by Treatment (Medical Devices, Medicines, Surgery), by Type (Diagnosis, Prognosis), by Stage (Stage A, Stage B, Stage C, Stage D), by End User (Clinic, Hospital, Medical Research Organization), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Heart Failure Therapeutics Market is valued at approximately USD 23.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.46% over the forecast period 202...
October 2024
285 pages
Asia Pacific Liver Disease Treatment Market - 2024-2031
US$ 2,499.00
Asia Pacific Liver Disease Treatment Market reached US$ 3.84 billion in 2023 and is expected to reach US$ 5.83 billion by 2031, growing with a CAGR of 5.50% during the forecast period 2026-2031. The A...
October 2024
62 pages
Latin America Liver Disease Treatment Market - 2024-2031
US$ 2,499.00
Latin America Liver Disease Treatment Market reached US$ 1.3 billion in 2023 and is expected to reach US$ 2.02 billion by 2031, growing with a CAGR of 5.80% during the forecast period 2026-2031. The L...
October 2024
63 pages
Phenylephrine Hydrochloride Market - 2024-2031
US$ 3,400.00
The Phenylephrine Hydrochloride Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
September 2024
53 pages
Botulinum Toxin Market - 2024-2031
US$ 3,400.00
Botulinum Toxin Marketis is growing with a CAGR of 7.62% during the forecast period 2026-2035. The Botulinum Toxin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...
September 2024
41 pages
